Why the study?
Does the loss of individual SFK isoforms (Fgr or Lyn) reduce atherosclerotic disease burden in ApoE-/- mice?
Population
Single SFK knockout mice crossed with the ApoE-/- model of atherosclerosis, and in vitro adhesion assays
Comparison
Genetic deletion of single SFK isoforms vs ApoE-/- mice with intact SFK (implied)
Design
Preclinical
Authors
Loading...
No change to clinical practice; leaves open whether isoform-specific SFK inhibition reduces human atherosclerotic burden.
Does the loss of individual SFK isoforms (Fgr or Lyn) reduce atherosclerotic disease burden in ApoE-/- mice?
Individual Src family kinases (Fgr and Lyn) operate in a non-redundant manner to regulate platelet-dependent monocyte recruitment and atherosclerotic disease burden, highlighting them as potential therapeutic targets.
Harrison et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: